{
    "root": "303d9134-594c-63c6-e063-6394a90a4edf",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Cefuroxime axetil",
    "value": "20250313",
    "ingredients": [
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CALCIUM STEARATE",
            "code": "776XM7047L"
        },
        {
            "name": "CALCIUM CARBONATE",
            "code": "H0G9379FGK"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "ALUMINUM OXIDE",
            "code": "LMI26O6933"
        },
        {
            "name": "CEFUROXIME AXETIL",
            "code": "Z49QDT0J8Z"
        }
    ],
    "indications": "cefuroxime axetil tablet cephalosporin antibacterial indicated treatment following infections due susceptible bacteria : ( 1 ) pharyngitis/tonsillitis ( adults pediatric patients ) ( 1.1 ) acute bacterial otitis media ( pediatric patients ) ( 1.2 ) acute bacterial maxillary sinusitis ( adults pediatric patients ) ( 1.3 ) acute bacterial exacerbations chronic bronchitis ( adults pediatric patients 13 years older ) ( 1.4 ) uncomplicated skin skin-structure infections ( adults pediatric patients 13 years older ) ( 1.5 ) uncomplicated urinary tract infections ( adults pediatric patients 13 years older ) ( 1.6 ) uncomplicated gonorrhea ( adults pediatric patients 13 years older ) ( 1.7 ) early lyme disease ( adults pediatric patients 13 years older ) ( 1.8 ) reduce development drug-resistant bacteria maintain effectiveness cefuroxime axetil antibacterial drugs , cefuroxime axetil used treat prevent infections proven strongly suspected caused bacteria .",
    "contraindications": "tablets oral suspension bioequivalent therefore substitutable milligram-per-milligram basis . ( 2.1 ) administer tablets without food . ( 2.2 ) administer cefuroxime axetil tablets described guidelines . ( 2.2 ) adjustment required patients impaired renal function . ( 2.5 ) adult patients pediatric patients guidelines cefuroxime axetil tablets infection duration ( days ) adults adolescents ( 13 years older ) pharyngitis/tonsillitis ( mild moderate ) 250 mg every 12 hours 10 acute bacterial maxillary sinusitis ( mild moderate ) 250 mg every 12 hours 10 acute bacterial exacerbations chronic bronchitis ( mild moderate ) 250 500 mg every 12 hours 10 uncomplicated skin skin-structure infections 250 500 mg every 12 hours 10 uncomplicated urinary tract infections 250 mg every 12 hours 7 10 uncomplicated gonorrhea 1,000 mg single dose early lyme disease 500 mg every 12 hours 20 pediatric patients younger 13 years ( swallow tablets whole ) acute bacterial otitis media 250 mg every 12 hours 10 acute bacterial maxillary sinusitis 250 mg every 12 hours 10",
    "warningsAndPrecautions": "cefuroxime axetil tablets , usp cefuroxime axetil tablets , usp 500 mg cefuroxime ( cefuroxime axetil ) , blue , capsule-shaped , biconvex , film-coated tablets 203 `` debossed one side plain side follows : 14 tablets/bottle ndc 72789-035-14 20 tablets/bottle ndc 72789-035-20 60 tablets/bottle ndc 72789-035-60 store 20° 25°c ( 68° 77°f ) . [ usp controlled room temperature ] . replace cap securely opening .",
    "adverseReactions": "cefuroxime axetil contraindicated patients known hypersensitivity ( e.g . , anaphylaxis ) cefuroxime axetil β-lactam antibacterial drugs ( e.g . , penicillins cephalosporins ) .",
    "indications_original": "Cefuroxime axetil tablet is a cephalosporin antibacterial drug indicated for the treatment of the following infections due to susceptible bacteria: (1) Pharyngitis/tonsillitis (adults and pediatric patients) ( 1.1 ) Acute bacterial otitis media (pediatric patients) ( 1.2 ) Acute bacterial maxillary sinusitis (adults and pediatric patients) ( 1.3 ) Acute bacterial exacerbations of chronic bronchitis (adults and pediatric patients 13 years and older) ( 1.4 ) Uncomplicated skin and skin-structure infections (adults and pediatric patients 13 years and older) ( 1.5 ) Uncomplicated urinary tract infections (adults and pediatric patients 13 years and older) ( 1.6 ) Uncomplicated gonorrhea (adults and pediatric patients 13 years and older) ( 1.7 ) Early Lyme disease (adults and pediatric patients 13 years and older) ( 1.8 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefuroxime axetil and other antibacterial drugs, cefuroxime axetil should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.",
    "contraindications_original": "Tablets and oral suspension are not bioequivalent and are therefore not substitutable on a milligram-per-milligram basis. ( 2.1 ) Administer tablets with or without food. ( 2.2 ) Administer cefuroxime axetil tablets as described in the dosage guidelines. ( 2.2 ) Dosage adjustment is required for patients with impaired renal function. ( 2.5 ) Adult Patients and Pediatric Patients Dosage Guidelines for Cefuroxime Axetil Tablets Infection Dosage Duration (Days) Adults and Adolescents (13 years and older) Pharyngitis/tonsillitis (mild to moderate) 250 mg every 12 hours 10 Acute bacterial maxillary sinusitis (mild to moderate) 250 mg every 12 hours 10 Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 250 or 500 mg every 12 hours 10 Uncomplicated skin and skin-structure infections 250 or 500 mg every 12 hours 10 Uncomplicated urinary tract infections 250 mg every 12 hours 7 to 10 Uncomplicated gonorrhea 1,000 mg single dose Early Lyme disease 500 mg every 12 hours 20 Pediatric Patients younger than 13 years (who can swallow tablets whole ) Acute bacterial otitis media 250 mg every 12 hours 10 Acute bacterial maxillary sinusitis 250 mg every 12 hours 10",
    "warningsAndPrecautions_original": "Cefuroxime axetil tablets,USP\n                  \n                  \n                  \n                  Cefuroxime Axetil Tablets,USP 500 mg of cefuroxime (as cefuroxime axetil), are blue, capsule-shaped, biconvex, film-coated tablets with 203'' debossed on one side and plain on the other side as follows:\n                  \n                  14 Tablets/Bottle                      NDC 72789-035-14\n  \n                     \n20 Tablets/Bottle                      NDC 72789-035-20\n  \n                     \n60 Tablets/Bottle                      NDC 72789-035-60\n  \n                  \n                  \n                  \n                  \n                  \n                  \n                     \n                     \n                     Store at 20° to 25°C (68° to 77°F).  [See USP controlled room temperature]. Replace cap securely after each opening.",
    "adverseReactions_original": "Cefuroxime axetil is contraindicated in patients with a known hypersensitivity (e.g., anaphylaxis) to cefuroxime axetil or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins)."
}